Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
https://www.sbcnews.co.uk/sportsbook/2022/01/28/low6-completes-5m-funding-round-ahead-of-ipo/
Hi Kenny, thanks for providing the information on Aion. I feel an important revenue generation announcement cannot be far off now.
Keep the faith....at least that is what I keep telling myself.
Buys still showing as sells as they are below the mid price........
If I get my original investment back in AfriAg I would be very happy. I have however continued to buy shares in Apollon as I like the story, so overall I still anticipate seeing a profit if/when the licencing agreements are signed.
Certainly keeping the company in the business news:
https://www.investegate.co.uk/apollon-formularies--apol-/rns/chief-science-officer-appointed-as-board-director/202201270701118279Z/
https://www.investegate.co.uk/apollon-formularies--apol-/rns/ceo-review-of-2021/202201250700074549Z/
Decent buy today on Aquis:
12.01.22 | 15:26:26 1175638 0.8495
Stephen D. Barnhill, M.D. CEO of Apollon, commented , "We are delighted to welcome Rod to the Board as a Non-Executive Director. Rod, a significant shareholder in the Company, has a long-established career with a demonstrable record of growing small cap companies and creating shareholder value of many business ventures over a long career. He brings a wealth of financial and directorial experience to the team, and I look forward to working with him as we move our business towards the global rollout of Apollon's product range and medical expertise to supportive jurisdictions."
Rod McIllree, Non-Executive Director, stated, "Apollon is an excellent example of utilising research and development to help improve people's lives. The compelling results of Apollon's formulations killing cancer cells in 3D-cell culture and the upcoming opening of the International Cancer and Chronic Pain Institute in Jamaica are important milestones for the Company and offers outstanding potential on many fronts. I look forward to working with Dr Barnhill and the wider Apollon team at this exciting time for growth as the Company looks to execute on the various business partnership opportunities becoming available."
https://www.investegate.co.uk/apollon-formularies/apol/appointment-of-non-executive-director/202201120700051378Y/?fe=1&utm_source=FE%20Investegate%20Alerts&utm_medium=Email&utm_content=Announcement%20Alert%20Mail&utm_campaign=Apollon+Formularies%20Alert
This will hopefully raise a bit of interest here.
https://www.investegate.co.uk/apollon-formularies--apol-/rns/approval-of-medical-cannabis-license-renewals/202201061025066523X/
Another box ticked...
Birmingham, UK (January 4, 2022) – Low6, the award-winning leaders in sports gamification, has announced the appointment of Ben Barker as Chief Revenue Officer. Barker, a global sports industry specialist with over 20 years experience working worldwide, joins Low6 from his most recent role as Chief Commercial Officer at Monterosa, where he worked with broadcasters, brands and sports rights-holders to activate mobile audiences. Barker starts at Low6 with immediate effect and will be responsible for developing commercial and revenue strategies to drive the expansion of the company in North America, whilst also looking to develop the company’s existing partnerships.
“We’re delighted to welcome Ben to Low6 as Chief Revenue Officer,” commented Jamie Mitchell, Co-Founder and Group CEO, Low6. “Ben has an outstanding resumé as a leader in global sports, with experience in multiple aspects of the industry, including broadcast, working with rights holders and brands, and in digital. Ben will add significant value to our leadership team as we continue to grow, and we look forward to seeing Ben play a major role in our growth plans for 2022 and beyond.”
Ben Barker, Chief Revenue officer, Low 6: “Low6 has made its mark as one of the hottest start-ups in sports gaming under Jamie’s leadership. I am excited to join the team to drive forward the commercial strategy aligning our partners, customers and fans to inspire sports gaming through innovation and creative solutions.”
A graduate of the University of Northumbria with a BA in Marketing / Marketing Management, Barker’s career includes 15 years at WPP Group companies and most recently 6 years with Monterosa Ltd working with IMG Arena, EA Sports, ViacomCBS, the Jockey Club, Formula 1 and Liverpool FC.
– END –
About Low6??
Low6 is a leader in sports gaming technology that powers franchises with their own branded gaming experiences to engage and monetize their digital fanbases. For the fans, by the fans – Low6 inspires innovative and creative solutions that redefines future sports mobile gamification. Low6 is proud partners of the PGA TOUR, DP WORLD Tour, UFC, NFL’S Jacksonville Jaguars and the Cincinnati Bengals, and the NBA Detroit Pistons. Low6 was the recipient of “Innovation of the Year” at the 2021 EGR iGaming Awards, and was also awarded the “Virtual Sports & Fantasy Operator” and “Rising Star” at the EGR Operator Awards 2021. For more information go to Low6.com
–
For media enquiries,?
Mark Dennis?
Low6?
Head of Marketing
mark.dennis@low6.co.uk
Related News
Low6 Xmas Message
2021 Christmas Message
December 23, 2021
A Christmas message from Low6 and Co-Founder, Jamie Mitchell
Read Full Story
EGR Awards - Low6 - Operator Awards
Low6 becomes multi-award winning company at EGR Operator Awards 2021
November 29, 2021
Gamification company Low6 clocked up two awards in the capital last week
Read Full Story
Low6 - 300k - Users - Press Release - North America -
Eventually filled at 2.5p. Expecting to see a significant re-rate when licencing deal eventually lands.
Hi Kenny, just tried an order at 2.5p which hasn't been filled. Trying again at 2.6p.
We may finally see some movement...
Apollon using Twitter a lot at the moment and sounding upbeat.
Another positive development in the medical cannabis market:
https://www.forbes.com/sites/dariosabaghi/2021/12/20/pfizer-to-enter-the-medical-cannabis-industry-with-67-billion-acquisition/
Well....we have waited all this time, so what is a couple of years more.
I have actually added a few more today, but as usual it is showing as a sell because it is below the mid price.
Let's hope 2022 is the year when Apollon make significant inroads and agree a collaboration with at least one pharmaceutical company.